Partillion Bioscience Corporation Announces Seed Financing, Expanded Board, and New Partnership with Alloy Therapeutics

Financing will fund growth and expansion of new functional single-cell analysis and sorting product lines for drug discovery, enabled by Partillion’s proprietary Nanovial technology. LOS ANGELES, Sept. 26, 2023 /PRNewswire/ — Partillion Bioscience Corporation (“Partillion”), a life…

Click here to view original post